Enzon Pharmaceuticals's market cap is currently $9.41M. The company's EPS TTM is $0.003; its P/E ratio is 38.18; Enzon Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 26.00K	$ 701.00K	$ 52.00K	$ 207.00K
Gross Profit	$ 0.00	$ 26.00K	$ 701.00K	$ 52.00K	$ 207.00K
Operating Income	$ -1.04M	$ -1.03M	$ -469.00K	$ -1.30M	$ -973.00K
EBITDA	$ 1.22M	$ 0.00	$ 0.00	$ 0.00	$ -973.00K
Net Income	$ 98.00K	$ -186.00K	$ -469.00K	$ -1.31M	$ -979.00K
Balance Sheet
Cash & Short-Term Investments	$ 47.01M	$ 46.98M	$ 47.64M	$ 48.14M	$ 5.45M
Total Assets	$ 47.70M	$ 47.59M	$ 47.75M	$ 48.23M	$ 6.48M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -47.01M	$ -46.98M	$ -47.64M	$ -48.14M	$ -5.45M
Total Liabilities	$ 1.71M	$ 1.70M	$ 403.00K	$ 412.00K	$ 423.00K
Stockholders' Equity	$ 45.99M	$ 45.89M	$ 47.35M	$ 47.82M	$ 6.05M
Cash Flow
Free Cash Flow	$ 1.30M	$ -659.00K	$ -501.00K	$ -380.00K	$ 6.91M
Operating Cash Flow	$ 1.30M	$ -659.00K	$ -501.00K	$ -380.00K	$ 6.91M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ -1.27M	$ -1.27M	$ -2.02M	$ 43.08M	$ -7.96M

Currency in USD

Enzon Pharmaceuticals Earnings and Revenue History

Income Statement >

Enzon Pharmaceuticals Debt to Assets

Balance Sheet >

Enzon Pharmaceuticals Cash Flow

Cash Flow >

Enzon Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing